Ophthalmology Ward 2

The Department of Ophthalmology of the Second Affiliated Hospital of Harbin Medical University was established in 1954. Under the successive leadership of several generations of renowned ophthalmology experts, including Professor Jing Chongde, Professor Wang Baolin, Professor Lü Shirong and Professor Yuan Huiping, the Department of Ophthalmology of the Second Affiliated Hospital of Harbin Medical University has become one of the nationally renowned ophthalmology centers and is a key discipline of Heilongjiang Province. In 2009 it was approved as a standardized training base for physicians of the Ministry of Health, in 2012 it was approved as a national key clinical specialty construction project, in 2017 the glaucoma specialty was recognized as a first-class specialty under the hospital's key construction, in 2018 it took the lead in establishing the Glaucoma Alliance of the Four Northeastern Provinces, in 2020 it was approved as the Heilongjiang Provincial Branch of the National Clinical Medical Research Center for Eye Diseases and in the same year took the lead in establishing the Heilongjiang Provincial Fundus Disease Alliance, and in 2022 it was approved as a Clinical and Research Center for Diabetic Retinopathy.

Today the expert team of the Department of Ophthalmology of the Second Affiliated Hospital of Harbin Medical University is strong, and under the leadership of Professor Sun Dawei, Director of Ophthalmology, discipline leader and Director of the Teaching and Research Section, its medical, teaching, research and academic levels continue to write brilliance. The medical team has 34 teachers, including 16 professors and 8 associate professors; 10 doctoral supervisors and 19 master's supervisors. It is responsible for the theoretical and clinical teaching of ordinary undergraduates, the clinical 5+3 program, graduate students and international students. The clinical work of the Department of Ophthalmology of the Second Affiliated Hospital of Harbin Medical University covers ten subspecialties, including glaucoma, fundus diseases, cataract, corneal and ocular surface diseases, oculoplastic and orbital diseases, ocular trauma, strabismus and pediatric eye diseases, uveitis, optometry and medical refraction.

The Department of Ophthalmology includes seven departments: the ophthalmology outpatient clinic, the ophthalmology ward, the ophthalmology center operating rooms, the ophthalmology refractive center, the ophthalmology imaging diagnosis and treatment center, the intravitreal injection center and the ophthalmology prosthesis center. The department has a complete range of technical units and well-equipped professional equipment. For three consecutive years from 2020 to 2022 it was a nominated hospital (among the top 20 nationwide) in the ophthalmology specialty of the "Fudan University Hospital Rankings — National Specialty Reputation Rankings", and it is the only nominated hospital in Northeast China; in 2021 and 2022 it ranked first in ophthalmology in Northeast China.

The expert team of Ophthalmology Ward II specializes in the treatment of refractory fundus diseases, complex cataract and other subspecialty directions, covering vitreoretinal diseases, choroidal diseases, ocular trauma, pediatric fundus diseases, corneal diseases, glaucoma, strabismus, orbital diseases and ocular tumors. Ophthalmology Ward II is the lead unit for fundus diseases in Heilongjiang Province; under the leadership of Director Sun Dawei, its outpatient and surgical volumes for fundus diseases rank among the foremost in Northeast China, and it also undertakes a large amount of consultation and treatment work for refractory fundus diseases within the province. It is the only unit in the province carrying out treatment of pediatric fundus diseases, taking the lead in carrying out clinical work such as pediatric fundus disease screening, intravitreal injection, laser and surgery, and it is also the only ward in the department carrying out routine corneal transplantation. In 2020 Director Sun Dawei took the lead in establishing the Heilongjiang Provincial Fundus Disease Alliance and serves as its chair unit; in 2022 it was approved as a Clinical and Research Center for Diabetic Retinopathy. The "Heilongjiang Provincial Fundus Disease Vitrectomy Training Course" and the "Grassroots Physician Fundus Disease Training" held regularly every year have injected vitality into the development of fundus diseases in our province. The experts of Ophthalmology Ward II have presided over a total of 10 National Natural Science Foundation projects, won 4 second prizes of the provincial government, and published more than 80 SCI articles; among the expert team there is 1 supervisor of the Wu Liande Class (integrated bachelor's, master's and doctoral program), 4 doctoral supervisors and 9 master's supervisors, and the ophthalmology graduate students trained over the years are spread all over the country, contributing to the cause of ophthalmology of the country and Northeast China.